LifeVantage Co. (NASDAQ:LFVN – Get Free Report) declared a quarterly dividend on Wednesday, August 28th, Zacks reports. Stockholders of record on Monday, September 9th will be paid a dividend of 0.04 per share on Tuesday, September 17th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date of this dividend is Monday, September 9th.
LifeVantage has a payout ratio of 22.9% meaning its dividend is sufficiently covered by earnings.
LifeVantage Price Performance
Shares of LFVN opened at $9.77 on Friday. LifeVantage has a 12 month low of $4.20 and a 12 month high of $10.48. The stock has a market cap of $124.09 million, a PE ratio of 34.89 and a beta of 0.81. The stock’s 50-day moving average is $7.47 and its two-hundred day moving average is $7.03.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Featured Articles
- Five stocks we like better than LifeVantage
- How to invest in marijuana stocks in 7 steps
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
- Business Services Stocks Investing
- Cloud Security Stocks Face Off: Find Out Who’s Leading the Market
- What is the S&P/TSX Index?
- Defensive Sectors: Shielding Your Portfolio in Volatile Times
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.